Patients receiving Eli Lilly’s diabetes medicine Mounjaro were “significantly more likely” to achieve clinically meaningful weight loss compared to those on Novo Nordisk’s Ozempic, according …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A popular biologic medicine used to combat autoimmune diseases cost Medicare and its beneficiaries considerably more when the injectable treatment was obtained at pharmacies rather
Share this article Amgen is focusing its endeavours on innovation within the obesity space. Credit: MargJohnsonVA via Shutterstock. On Monday 9 January 2024, Amgen presented
PHOENIX – Generalized myasthenia gravis patients had dramatically lower incidence of flares and crises after starting on the complement component 5 inhibitor eculizumab (Soliris), data